Comment
doi: 10.1200/JCO.19.01163.
Epub 2019 Sep 25.
Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions
Affiliations
- PMID: 31553677
- DOI: 10.1200/JCO.19.01163
Item in Clipboard
Comment
Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions
J Clin Oncol.
.
No abstract available
Comment in
-
Reply to F. Tomao et al and E.A. De Jaeghere et al.J Clin Oncol. 2019 Nov 20;37(33):3170. doi: 10.1200/JCO.19.02091. Epub 2019 Sep 25. J Clin Oncol. 2019. PMID: 31553678 No abstract available.
Comment on
-
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.J Clin Oncol. 2019 Jun 1;37(16):1380-1390. doi: 10.1200/JCO.18.01568. Epub 2019 Apr 19. J Clin Oncol. 2019. PMID: 31002578 Free PMC article. Clinical Trial.
Similar articles
-
Front-line therapy of advanced epithelial ovarian cancer: standard treatment.Ann Oncol. 2017 Nov 1;28(suppl_8):viii36-viii39. doi: 10.1093/annonc/mdx450. Ann Oncol. 2017. PMID: 29232473 Review.
-
Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer.Eur J Pharmacol. 2018 Oct 15;837:64-71. doi: 10.1016/j.ejphar.2018.07.049. Epub 2018 Jul 27. Eur J Pharmacol. 2018. PMID: 30059681
-
Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?Gynecol Oncol. 2017 Feb;144(2):238-240. doi: 10.1016/j.ygyno.2016.11.046. Epub 2016 Dec 22. Gynecol Oncol. 2017. PMID: 28017307 No abstract available.
-
Is intraperitoneal chemotherapy still an acceptable option in primary adjuvant chemotherapy for advanced ovarian cancer?Ann Oncol. 2017 Nov 1;28(suppl_8):viii40-viii45. doi: 10.1093/annonc/mdx451. Ann Oncol. 2017. PMID: 29232474 Review.
-
Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial.Med Oncol. 2015 Feb;32(2):292. doi: 10.1007/s12032-014-0292-1. Epub 2015 Jan 22. Med Oncol. 2015. PMID: 25609006 Clinical Trial.
Cited by
-
Should We Abandon Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer? A Meta-Analysis.J Pers Med. 2023 Nov 23;13(12):1636. doi: 10.3390/jpm13121636. J Pers Med. 2023. PMID: 38138863 Free PMC article. Review.
-
Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences.Front Med (Lausanne). 2022 Mar 17;9:846352. doi: 10.3389/fmed.2022.846352. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35372416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
